Background Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal
antibody that has been shown to safely reduce exacerbations and improve lung function for …

The anti-asthmatic effects of theophylline may supplement those of inhaled steroids in
asthma. The aim of the present trial was to study how the addition of theophylline compares to …

Background: Roflumilast is an oral, once‐daily phosphodiesterase 4 inhibitor with anti‐inflammatory
activity in development for the treatment of asthma. Roflumilast was compared with …

… For symptom scores and daily use of rescue medication, the Pratt modification of the Wilcoxon
signed rank test was applied for within-group comparisons, and the Mann-Whitney U test …

Mometasone furoate (MF) administered by dry powder inhaler (DPI) was composed with
budesonide (BUD) Turbuhaler in the treatment of moderate persistent asthma. The patients …

Background: Chronic obstructive pulmonary disease (COPD) management guidelines
recommend regular treatment with one or more long-acting bronchodilators for patients with …

Background. Inhaled corticosteroids (ICSs) are one of the suggested first-line therapies for
patients with persistent asthma of moderate severity. Methods: The efficacy and safety of …

The anti-asthmatic effect of theophylline may supplement those of inhaled steroids in asthma.
The aim of the present trial was to study how the addition of theophylline compares to …

RATIONALE: Patients with allergic asthma (AA) frequently experience concomitant persistent
allergic rhinitis (PAR). Omalizumab, a humanized monoclonal anti-IgE antibody, improves …

N-Acetyl-aspartyl magnesium glutamate (Rhinaaxia, NAAGA) is a new antiallergic substance
for topical use. The compound covers a bilateral way of action. There is inhibition of the …